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With the open letter published in EJNMMI Radiopharmacy and Chemistry by an
international working group of experts, the EJNMMI journal family endorses the
application of the guidelines in contributions to the journals.
Attached to the letter by the working group is a three-page summary highlighting
the most relevant issues used in the notation of radiopharmaceuticals and related
terms.
The full paper with all recommendations is published in “Consensus nomencla-
ture rules for radiopharmaceutical chemistry—setting the record straight, Coenen,
H.H., Gee A.D. et al., Nuclear Medicine and Biology, Volume 55, v – xi (2017)
(https://doi.org/10.1016/j.nucmedbio.2017.09.004)”.
All Editors-in-Chiefs of the EJNMMI journals strongly recommend all manu-
scripts meet these guidelines upon submission. In addition, all reviewers will be
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